Chamber and committees

Witnesses can come in if they have a specific position on that, but they should not feel under any pressure to do so.

Thank you all. Douglas Lumsden has questions on targets and restrictions, and then Monica Lennon has some last questions for Henry Irving.

Douglas, perhaps you could address your questions to Toni Freitas and Melissa Marques-McEwan.

Professor McHarg has indicated that she would like to say something on that matter.

Witnesses can have a couple of sentences but just not too many. [Laughter.]

Charis, do you want to come in on those points?

Briefly, please.

Unless witnesses have any particular international examples that they want to emphasise, I will move on to Brian Whittle, who has some questions.

I understand that Jocelyn Blériot wants to comment, too.

Before you do, Monica Lennon has a quick supplementary on this area.

The evidence that we have heard today has been interesting and helpful. Thank you all for your time and for sharing your insights and perspectives. We have obviously got through quite a lot today, and you have provided examples and ideas.

If, after the meeting, there are points on which you want to follow up—whether they are on more that you would like to see in the bill or on points that come to mind that you wish that you had made—please get in touch with us. Some of you made commitments to share more information with the committee; we are grateful in advance to you for providing that.

Thank you again for sharing your views and time. Our stage 1 report will be published in January next year, and the clerks will ensure that a copy of the report is shared with you.